A LECT2-eluting in situ coaxial electrospun nanofiber dressing orchestrates oxidative stress resolution and immune reprogramming for accelerated wound healing Authors: Zhichao Zheng, Jiasheng Mao, Haohui Zhu, Zhihe Fu, Wei Xie, Shaofen Xu, Yan Wang, Shuiqing Yu, Ziyi Liu, Lijing Wang, Richard T. Jaspers, Janak L. Pathak, Huade Zheng, Lihong Wu Published: 2026 ABSTRACT BackgroundThe development of multifunctional dressings capable of actively orchestrating the complex wound microenvironment remains a critical challenge in regenerative medicine. Although leucocyte cell-derived chemotaxin-2 (LECT2) has been implicated in inflammation and angiogenesis, its therapeutic potential in wound healing remains unexplored.ResultsHere, we report a novel, portable coaxial electrospinning system for the in situ fabrication of a bioactive nanofiber dressing that continuously delivers functional LECT2. This dressing features a unique polyvinyl butyral (PVB)/polyvinylpyrrolidone (PVP) core and a polyvinyl alcohol (PVA)/PVP shell, which together ensure sustained LECT2 release. We demonstrate that LECT2 acts as a potent multi-target agent: it directly scavenges reactive oxygen species by upregulating the NRF2/SOD axis in keratinocytes and fibroblasts, promotes angiogenesis under oxidative stress, and exerts antimicrobial activity against S. aureus and Methicillin-resistant Staphylococcus aureus. Crucially, LECT2 drives immune reprogramming by polarizing macrophages toward a pro-regenerative M2 phenotype. The resulting dressing exhibits excellent mechanical properties and air permeability, and facilitates rapid wound closure in vivo by simultaneously enhancing re-epithelialization, neovascularization, and M2 macrophage polarization. Conclusions: This work not only unveils LECT2 as a master regulator of wound healing but also establishes a versatile platform for in situ fabrication of advanced dressings, with great promise for the treatment of complex skin wounds. Introduction As the largest organ of the human body, the skin serves as an indispensable physical and immune barrier, preventing dehydration, temperature dysregulation, and microbial invasion [1]. Breach of this barrier through traumatic injury represents a significant clinical challenge, contributing to hundreds of thousands of deaths and millions of disabilities worldwide each year [1,2]. A skin wound disrupts the local immune microenvironment, elevating the risk of infection and compromising the body's ability to initiate repair, a process that relies on the coordinated regulation of cell migration, macrophage polarization, angiogenesis, and redox balance [3]. Interestingly, the pleiotropic cytokine LECT2 is elevated and aggravates the inflammation of macrophages in steatosis [4]. High dose (400 ng/mL) of LECT2 exacerbates ethanol-induced liver injury by promoting reactive oxygen species (ROS) through its interaction with prohibitin 2 [5]. Furthermore, elevated LECT2 levels inhibit angiogenic formation in liver fibrosis patients [6]. However, the role of physiological LECT2 level in cutaneous wound healing has not been investigated. An ideal wound dressing should not only manage exudate and maintain a moist environment but also serve as a barrier against pathogens and actively regulate the immune landscape to facilitate tissue repair [7]. Although traditional options such as gauze are cost-effective and highly absorbent, they often lack intrinsic antibacterial properties and can cause secondary injury upon removal due to tissue adhesion. In contrast, nanofiber membranes have emerged as advanced bioactive dressings owing to their structural resemblance to the native extracellular matrix (ECM) [8]. Among various nanofiber fabrication techniques, electrospinning stands out due to its cost-effectiveness, high efficiency, and scalability. However, conventional monoaxial electrospinning offers limited control over the release kinetics of therapeutic agents. To address this limitation, coaxial electrospinning (CES) has been developed, enabling the fabrication of core-shell fibers that support sustained and efficient drug delivery [9]. This capability is particularly critical for delivering bioactive factors, such as growth factors (e.g., EGF, VEGF, FGF), which are potent yet often have short half-lives and are rapidly degraded in the wound environment. Given that LECT2 is a protein-based bioactive factor, we hypothesized that incorporating it into a coaxial electrospun fiber (CEFs) matrix could preserve its bioactivity and ensure stable, sustained release at the wound site. Building on this rationale, CEFs have been increasingly explored for wound healing. For instance, engineered CEFs have been used to deliver a range of therapeutic agents, including stromal cell-derived factor-1α (SDF-1α) [10], basic fibroblast growth factor (bFGF) [11], insulin [12], platelet-derived growth factor (PDGF) [13], and components of platelet-rich fibrin [14], demonstrating enhanced repair in diabetic and other wound models. Although these studies validate the efficacy of CEFs, they predominantly rely on polymers like PLGA, PCL, and PHB, which require toxic organic solvents (e.g., chloroform, hexafluoroisopropanol) for processing. Residual solvent poses biocompatibility risks, necessitating post-fabrication washing steps that preclude immediate in situ application. This limitation is particularly critical, given that the irregular geometry of most wounds requires direct bedside application of personalized dressings [15]. Although there has been a move towards portable electrospinning devices, such as a handheld unit for depositing cool nanofibers onto burns [16], existing systems are often inflexible, with fixed-voltage settings incompatible with diverse polymer solutions, and still use skin-irritating solvents like acetone. Ethanol is an ideal green solvent for in situ electrospinning; existing reports predominantly focus on loading small-molecule organic compounds, which do not necessitate the preservation of complex active structures [17,18]. Although water is an excellent solvent for protein-based bioactive factors such as LECT2, water-soluble electrospun fibers typically require post-treatment (e.g., heating or crosslinking) to withstand moist environments, processes that inevitably compromise the active conformation of these factors. To address this, we developed a novel coaxial spinning system utilizing an aqueous core and an ethanol-based shell. By modulating the spinning components to prevent the premature miscibility and subsequent clogging of water and ethanol at the needle tip, our system simultaneously preserves the bioactive conformation of LECT2 and ensures fiber stability in humid environments. Herein, we present a comprehensive strategy that unveils LECT2 as a critical mediator of wound healing and introduces a tailored platform for its clinical application. We demonstrate that genetic deletion of LECT2 impedes wound repair, whereas exogenous LECT2 orchestrates healing by enhancing cell migration, resolving oxidative stress, promoting M2 macrophage polarization, and stimulating angiogenesis. To facilitate clinical application, we developed a novel, voltage-tunable portable electrospinner and a biocompatible, ethanol-based coaxial system to fabricate LECT2-loaded core-shell fibers for controlled release. This integrated approach, combining a potent biologic with an advanced, safe delivery system, proved highly effective in vivo, significantly accelerating wound repair (Graphical abstract). Collectively, our study provides both a new biological insight and a pioneering therapeutic strategy for complex wound management. Experimental section Animal wound healing model Lect2-knockout (Lect2-KO) mice were generated as previously described [6]. A full-thickness excisional wound model was employed. Briefly, a 1 cm diameter circular wound was created on the dorsum of anesthetized wild-type (C57BL/6J) and Lect2-KO mice using surgical scissors [3]. The direct effect of LECT2 on wound healing were detected. After wound was created, 50 ng/mL, and 100 ng/mL LECT2 (50 μL) was dipped on the wound area on day 0. Wound areas were photographed and quantified using Image J on days 1, 3, 5, 7, and 10 post-wounding. Wound closure percentage was calculated as: [(Initial area - Area on day n)/Initial area] × 100. All animal procedures were approved by the Laboratory Animal Ethics Committee of Guangdong Huawei Testing Co., Ltd., Guangzhou, China (Approval No: 202202002) and conducted in accordance with relevant guidelines and regulations. Histological analysis (H&E staining) Upon completion of the study, skin wound tissues and major organs (heart, liver, spleen, lungs, and kidneys) were harvested and fixed in 4% paraformaldehyde for 48 h. The tissues were subsequently processed, embedded in paraffin, and sectioned at 4-5 μm thickness. Hematoxylin and eosin (H&E) staining was performed according to our standard laboratory protocol [19] to assess general tissue morphology and re-epithelialization. Immunohistochemistry (IHC) Immunohistochemical analysis was performed as previously described [20] with minor modifications. Briefly, deparaffinized and rehydrated tissue sections were subjected to heat-induced antigen retrieval in citrate buffer. Endogenous peroxidase activity was quenched by incubation with 3% hydrogen peroxide for 25 min at room temperature. Non-specific binding sites were blocked with 3% bovine serum albumin (BSA) for 30 min. The sections were then incubated overnight at 4°C with the following primary antibodies diluted in blocking solution: rabbit polyclonal anti-CD31 (1:300, Servicebio), anti-Ki67 (1:200, Servicebio), anti-CD206 (1:300, Servicebio), and anti-CD86 (1:300, Servicebio). After washing with PBS, the sections were incubated with an HRP-conjugated goat anti-rabbit IgG secondary antibody (1:500, Servicebio) for 1 h at room temperature. Signal detection was performed using a 3,3′-diaminobenzidine (DAB) substrate kit, followed by counterstaining with hematoxylin. Stained sections were imaged using a light microscope. The preparation and evaluation of the LECT2 incorporated coaxial fibers Materials: Polyvinyl butyral (PVB; Mw = 170,000–250,000 g/mol), polyvinylpyrrolidone (PVP; K90), polyvinyl alcohol (PVA; 75 kDa, 87-89% hydrolysis), and anhydrous ethanol (99.5%) were used as received. Cy5-NHS ester was obtained from Dalian Bergolin Biotechnology Co., Ltd. Dialysis membranes (MWCO: 7 kDa) were purchased from Yuanye Bio-Technology Co., Ltd. Fabrication of Coaxial Fibers: Core-shell fibers were fabricated via coaxial electrospinning (Supplementary video). For the shell solution, PVB and PVP were dissolved in anhydrous ethanol at varying mass ratios and stirred at 800 rpm for 2 h at room temperature to obtain a homogeneous solution. For the core solution, PVA and PVP were dissolved in deionized water at different ratios under stirring at 600 rpm for 1 h at 95°C. Electrospinning was performed using a custom coaxial needle (22G for core, 17G for shell). The optimized parameters (see Table S2 for details) included a working distance of 20 cm, an applied voltage of 18 kV, and controlled environmental conditions (25°C, 45% relative humidity). The flow rates for the shell and core solutions were set at 3 mL/h and 1 mL/h, respectively. Fibers were collected on a rotating drum collector at 200 rpm. Supplementary data related to this article can be found online at https://doi.org/10.1016/j.mtbio.2026.103363 The following are the Supplementary data related to this article:Video 1 Video 1 Incorporation of LECT2: For drug-loaded fibers, LECT2 was incorporated into the core solution at a final concentration of 10 μg/mL. LECT2 was first gradually added to the spinning solution using an equal-volume dilution method, then the solution was gently stirred at 100 rpm for 1 h at 4°C to ensure homogeneous dispersion without compromising protein integrity. Synthesis of Cy5-Labeled LECT2: LECT2 was fluorescently labeled for visualization purposes. Briefly, LECT2 (10 μg/mL) and Cy5-NHS ester (10 μg/mL) were co-dissolved in 1 mL of PBS (pH 8.5) and allowed to react overnight at 4°C under gentle agitation at 60 rpm. The resulting mixture was dialyzed against PBS (7 kDa MWCO) for 48 h to remove unreacted dye, and the purified Cy5-LECT2 conjugate was obtained by lyophilization. Structural and physicochemical characterization Morphology: Fiber morphology was examined by scanning electron microscopy (SEM; FEI-Q25, ZEISS) at an accelerating voltage of 5 kV, following sputter-coating with a thin gold layer. The core-shell structure was confirmed by transmission electron microscopy (TEM; Talos L120c, Thermo Scientific) using fibers directly deposited onto copper grids. Chemical Composition: Fourier Transform Infrared (FTIR) spectroscopy (Thermo Nicolet iS50) was conducted over the range of 500-4000 cm−1 using KBr pellets containing finely cut fiber samples. Thermal Properties: Thermal stability was assessed by the thermogravimetric analysis (TGA; NETZSCH STA449F3). Approximately 10 mg samples were heated from 30 to 500°C at 15 °C/min under a nitrogen atmosphere. Confocal Laser Scanning Microscopy (CLSM): Successful encapsulation of LECT2 within the fiber core was visualized using a Leica TCS SP8 confocal microscope. Fibers were prepared with a core of Cy5-labeled LECT2 (red emission) and a shell solution doped with 0.1% (w/v) calcein (green emission). Hydrophilicity: The surface wettability of the fiber mats was evaluated by water contact angle (WCA) measurements using a DSA25 instrument (Krüss). A 10 μL droplet of deionized water was deposited on the fiber mat, and the static contact angle was recorded within 30 s. In Vitro Release Kinetics of LECT2: The release profile of LECT2 from the coaxial fibers was evaluated in vitro. LECT2-loaded nanofiber mats were cut into 6 × 10 cm2 sheets and immersed in 10 mL of PBS at 37°C under constant agitation (100 rpm). At predetermined time intervals (1, 2, 4, 8, 12, 24, 48, 72, 96, 120 h), 5 μL aliquots of the release medium were withdrawn and replaced with an equal volume of fresh PBS to maintain sink conditions. The concentration of released LECT2 in the collected samples was quantified using a commercial Enzyme-Linked Immunosorbent Assay (ELISA) kit (Wuhan Fine Biotech Co., Ltd., China) according to the manufacturer's instructions. Mechanical Characterization: The tensile properties of the nanofiber mats were assessed using a universal material testing machine (Instron 5967, USA). Samples were cut into rectangular strips (40 × 20 mm) of uniform thickness and subjected to uniaxial tension at a constant crosshead speed of 10 mm/min until failure. Young's modulus, tensile strength, and elongation at break were derived from the resulting stress-strain curves. Hydration Properties: The hydration performance of the fibers, which is critical for wound dressing applications, was evaluated through assessing water vapor transmission and swelling capacity [21]. The water vapor transmission rate (WVTR) was determined via the gravimetric cup method. Briefly, 1 mL of deionized water was added to a 1.8 mL vial, which was then sealed with the nanofiber membrane or a commercial dressing (gauze, hydrocolloid, or foam). The assembly setup was placed in a controlled environment, and weight loss was recorded daily for 3 days. The WVTR (g·m−2·day−1) was calculated using the equation: WVTR = (Wn - W0)/S, where Wn is the initial mass, W0 is the mass on day n (n = 1, 2, 3 …), and S is the exposed surface area of the vial. For swelling ratio analysis, the fluid absorption capacity was measured in accordance with the Chinese Pharmaceutical Industry Standard YY/T 0471.1-2004. Fiber samples (10 × 10 mm) were weighed to obtain their initial dry mass (WD). Subsequently, they were immersed in 2 mL of PBS at 37°C under agitation (100 rpm) for 24 h. The swollen samples were then carefully removed, surface moisture was blotted, and the wet weight (Ww) was recorded. The swelling ratio (Q) was calculated as follows.Q(%)=Ww−WDWD∗100% In vivo biocompatibility and therapeutic efficacy assessment The in vivo therapeutic effect and systemic biocompatibility of LECT2-incorporated coaxial electrospun fibers (LECT2-AP@BP) were evaluated in a murine model. All animal procedures were approved by the Institutional Animal Care and Use Committee of Guangdong Huawei Testing Co., LTD, Guangzhou, China (approved number: 202202002) and conducted in accordance with relevant guidelines. C57BL/6J mice (purchased from GemPharmatech Co., Ltd., China) were randomly assigned to three experimental groups (n = 6 per group): (1) a Control group (untreated or treated with blank fibers), (2) an AP@BP group (treated with drug-free core-shell fibers), and (3) a LECT2-AP@BP group (treated with LECT2-loaded fibers). The respective fibrous dressings were deposited directly onto full-thickness excisional wounds on the dorsum of the mice using an in situ electrostatic spinning device. At the end of the treatment period, mice were euthanized, and major organs (heart, liver, spleen, lungs, and kidneys) were harvested, fixed, and sectioned for H&E staining to assess histopathological changes and systemic toxicity. Concurrently, blood plasma was collected, and the levels of key biochemical markers, alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea (UREA), and creatinine (CREA) were quantified to evaluate hepatic and renal functions. Hemocompatibility test The hemolytic activity of LECT2 and related nanomaterials (AP@BP and LECT-AP@BP) was assessed using fresh rabbit red blood cells (RBCs). RBCs were washed and resuspended in PBS to 10% (v/v). Equal volumes of the RBC suspension and test samples were mixed and incubated at 37°C for 1.5 h. Following centrifugation (2500 rpm for 5 min), the supernatant was photographed, and its absorbance was measured at 540 nm. PBS and deionized water served as negative (0% hemolysis) and positive (100% hemolysis) controls, respectively. The hemolysis percentage was calculated as: (Abs_sample - Abs_negative)/(Abs_positive - Abs_negative) × 100%. Cell culture Human keratinocyte (HaCaT) cells were obtained from the National Collection of Authenticated Cell Cultures (China). Mouse fibroblast (L929) and mouse macrophage (Raw264.7) cell lines were procured from Procell (China). HaCaT and L929 cells were maintained in high-glucose Dulbecco's Modified Eagle Medium (H-DMEM), while Raw264.7 cells were cultured in α-MEM. All media were supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S). Human umbilical vein endothelial cells (HUVECs) were purchased from Oricell (China) and cultured in complete endothelial cell medium (Sciencell, USA). All cells were maintained at 37°C in a humidified atmosphere containing 5% CO2. Biocompatibility and cell viability assay The in vitro biocompatibility of LECT2 was evaluated across four cell lines, including HaCat, Raw264.7, L929, and HUVECs, to determine its effects on metabolic activity, a key indicator of cell viability. Cells were seeded in 96-well plates at a density of 3000 cells per well and exposed to a range of LECT2 concentrations (0, 1, 10, and 100 ng/mL). Viability was quantified using two distinct metabolic assays. First, a CCK-8 assay (Biosharp, China) was used to monitor proliferation over a 5-day period; at 1, 3, and 5 days of treatment, the reagent was added, followed by a 2-h incubation and absorbance measurement at 450 nm. Second, to validate these results, a PrestoBlue assay (Thermo Fisher, USA) was conducted following a 2-day treatment. After a 2-h incubation with the reagent, the fluorescence signal (Ex/Em: 570/600 nm) was measured. In both assays, untreated cells served as the control. Lentiviral knockdown and transduction Lentiviral plasmids for a non-targeting control (shCtrl) and for LECT2 knockdown (shLECT2) were sourced from Vectorbuilder (China). The target sequence for the LECT2-specific shRNA was 5′-GCAGAAAGTTTATCCTGGCAT-3’. For lentivirus production, HEK293T cells were co-transfected with the transfer plasmid (shCtrl or shLECT2) and the packaging plasmid pMD2. VSVG, pMDLg/pRRE, and pRSV-REV using EZ trans transfection reagent (Life-iLab, AC04L092). The viral supernatant was collected 48 h post-transfection, filtered through a 0.45 μm membrane, and used to infect target cells in the presence of 8 μg/mL polybrene. Cell migration assays Transwell Migration Assay: Cell migration was assessed using 24-well Transwell plates with 8 μm pore membranes (Corning, USA). Briefly, 5 × 104 HaCaT or L929 cells in serum-free medium were seeded into the upper chamber. The lower chamber was filled with complete medium containing 10% FBS as a chemoattractant. After 24 h of incubation, non-migrated cells on the upper surface of the membrane were removed with a cotton swab. Cells that had migrated to the lower surface were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet, and imaged. The number of migrated cells was quantified from five random fields per well under a light microscope. Wound Healing (Scratch) Assay: HaCaT or L929 cells were seeded in 48-well plates and grown to 100% confluence. A sterile 200 μL pipette tip was used to create a linear scratch in the cell monolayer. The wells were gently washed with PBS to remove detached cells, then incubated with M199 medium containing recombinant human LECT2 protein (FineBio, China) at 1, 10, and 100 ng/mL. Cell migration into the wound area was photographed at 0, 12, and 24 h post-scratching using an inverted microscope. The wound closure area was quantified using ImageJ software. Intracellular ROS detection Intracellular reactive oxygen species (ROS) levels were measured using the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA). HaCaT and L929 cells were first treated with 200 μM hydrogen peroxide (H2O2) for 3 h to induce oxidative stress. Subsequently, the cells were incubated with 10 μM DCFH-DA (Solarbio, CA1410) in serum-free medium at 37°C for 30 min in the dark. After incubation, the cells were gently washed twice with PBS to remove excess probe. Fluorescence imaging was immediately performed using an In Cell Analyzer 2500HS high-content analysis system (GE Healthcare, USA). The fluorescence intensity was quantified and analyzed using the system's accompanying software. Quantitative Real-Time PCR (RT-qPCR) Total RNA was extracted from cells using Trizol reagent (Accurate Biology, AG21102) according to the manufacturer's instructions, as previously described [19]. RNA concentration and purity were determined spectrophotometrically. Subsequently, 500 ng of total RNA was reverse-transcribed into cDNA using the Evo M-MLV Reverse Transcription Kit (Accurate Biology, AG11701). Quantitative PCR was performed using the SYBR® Green Premix Pro Taq HS qPCR Kit (Accurate Biology) on an AriaMx Real-Time PCR System (Agilent Technologies, USA). The PCR cycling conditions were as follows: initial denaturation at 95°C for 30 s, followed by 40 cycles of 95°C for 5 s and 60°C for 30 s. Relative mRNA expression levels were calculated using the 2^(–ΔΔCt) method, with GAPDH as the internal reference gene. All primer sequences are provided in Supplementary Table S1. Macrophage polarization analysis by flow cytometry Macrophage polarization was assessed by measuring the surface expression of the M1 marker CD86 and the M2 marker CD206 via flow cytometry. RAW 264.7 cells were seeded and stimulated with 1 μg/mL lipopolysaccharide (LPS) for 6 h to induce a pro-inflammatory state, followed by treatment with 10 ng/mL recombinant LECT2 protein for an additional 18 h. Following treatment, approximately 1 × 106 cells per sample were harvested. For surface staining, cells were incubated with an anti-mouse CD86/FITC antibody (1:200, Biolegend) in 100 μL PBS for 30 min at 4°C in the dark. Cells were then fixed, permeabilized using a commercial intracellular staining kit, and subsequently incubated with an anti-mouse CD206/APC antibody (1:200, Biolegend) for 1 h at 4°C in the dark. Following a final wash, the cells were resuspended in PBS and analyzed immediately on a BD FACS Canto II flow cytometer (BD Biosciences, USA). Data from at least 10,000 events per sample were collected and analyzed using FlowJo software (Tree Star, USA). Single-cell RNA sequencing (scRNA-seq) analysis Publicly available scRNA-seq data (GEO accession: GSE241132) comprising 61,817 cells from human wound skin biopsies at days 1, 7, and 30 post-injury (n = 3 individuals) were analyzed [19]. Data processing was performed using Seurat (v4.4.0). Low-quality cells were filtered out based on the following criteria: genes detected per cell (nFeature_RNA) between 500 and 9000, unique molecular identifiers per cell (nCount_RNA) greater than 1000, and mitochondrial gene ratio below 20%. Gene expression counts were log-normalized. Batch effects among individuals were corrected using the Harmony package (v1.2.0). Dimensionality reduction and visualization were conducted using Uniform Manifold Approximation and Projection (UMAP). Differential gene expression analysis across identified clusters was performed with the FindMarkers function. Angiogenic tube formation assay HUVECs were pre-treated with 200 μM H2O2 for 3 h to induce oxidative stress, followed by treatment with LECT2 at concentrations of 1, 10, or 100 ng/mL. Subsequently, HUVECs (1 × 104 cells/well) were seeded onto a growth factor-reduced. Matrigel matrix. Tube network formation was visualized using an inverted microscope, and total tube length was quantified using ImageJ software (v1.54g). Antibacterial and anti-biofilm assays The antibacterial activity of LECT2 was evaluated against Staphylococcus aureus (S.A.) and Methicillin-resistant Staphylococcus aureus (MRSA). For planktonic culture, bacteria (5 × 105 CFU/mL) were incubated with LECT2 (1, 10, 100 ng/mL) for 2 h at 37°C. Serial dilutions were plated on tryptic soytone agar, and bacterial viability was determined by colony-forming unit (CFU) counts after 16 h. For biofilm assay, biofilms were established in 96-well plates by incubating bacterial suspensions (107 CFU/mL) for 48 h at 37°C [3]. After PBS washing to remove non-adherent bacteria, biofilms were fixed with paraformaldehyde and stained with 0.1% (w/v) crystal violet. Excess stain was removed, and the bound crystal violet was solubilized. Biofilm biomass was quantified by measuring optical density at 590 nm using a Cytation 5 multi-mode reader (BioTek, USA). Statistical analysis All quantitative data are presented as the mean ± standard deviation (SD). Statistical significance between groups was determined using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test for multiple comparisons, implemented in GraphPad Prism software (version 9.5). A p-value of less than 0.05 was considered statistically significant. Results and discussion LECT2 improved skin wound healing To investigate the role of LECT2 in tissue repair, we evaluated excisional wound healing in Lect2-KO mice compared to WT controls. Lect2 deficiency significantly impaired the wound closure rate over time, as determined by serial planimetry (Fig. 1A–C). Histological analysis of wound sections at day 7 post-injury confirmed a substantially larger residual wound gap in Lect2-KO mice (Fig. 1D). Furthermore, immunohistochemical staining revealed a marked reduction in the proliferation marker Ki67 and the endothelial cell marker CD31 within the wound bed of knockout animals (Fig. 1E). The administration of LECT2 (50 ng/mL) also efficiently improved the skin wound healing, while 100 ng/mL LECT2 not (Fig. S1). Collectively, these data indicate that LECT2 is critical for efficient skin wound healing by promoting cellular proliferation and angiogenesis.Fig. 1Lect2 knockout mice showed compromised skin wound healing. (A) Macroscopic observation of wound healing. (B) Schematic diagram of wound healing area and (C) quantification of wound healing (%). (n = 8). (D) H&E-stained skin wound tissue sections. (E) The Immunohistochemistry staining and quantification of CD31 and Ki67 in skin wound tissue sections (n = 3). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Lect2 knockout mice showed compromised skin wound healing. (A) Macroscopic observation of wound healing. (B) Schematic diagram of wound healing area and (C) quantification of wound healing (%). (n = 8). (D) H&E-stained skin wound tissue sections. (E) The Immunohistochemistry staining and quantification of CD31 and Ki67 in skin wound tissue sections (n = 3). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Rational design and in situ fabrication of core-shell fibers for biofactor delivery To achieve localized and sustained delivery of bioactive LECT2, we engineered a portable coaxial electrospinning system for the in situ deposition of core-shell fibrous dressings. This design strategically isolates the LECT2-containing aqueous core within a protective polymer shell, thereby overcoming the critical challenge of preserving protein conformation while ensuring dressing stability in a moist wound environment. Our initial approach utilized a PVP/PVB shell (in ethanol) and a PVP/water core. Although the amphiphilicity of PVP was hypothesized to stabilize the solvent interface, this configuration failed to produce a stable compound Taylor cone (Fig. S3A). We attributed this failure to the high miscibility of water (ε ∼78.36) and ethanol (ε ∼24.3), an issue likely exacerbated by the presence of PVP in both phases. To deconvolute this effect, we systematically modified the polymer composition. Removing PVP from the core (PVA/water core with PVP/PVB shell) or from the shell (PVP/water core with PVB/ethanol shell) successfully yielded stable Taylor cones (Fig. S3B and S3C), confirming that a uniform PVP distribution disrupts the necessary phase separation. However, these configurations provided suboptimal: TEM revealed incomplete core encapsulation in PVA@PVP/PVB fibers (Fig. S3B), and PVP@PVB fibers exhibited extensive wrinkling and poor morphology (Fig. S3C). Through this iterative process, we arrived at an optimally balanced system: a PVP/PVA/water core and a PVP/PVB/ethanol shell. We propose that the extensive hydrogen-bonding network afforded by PVA in the core confers critical solution stability, while the strategic distribution of PVP enables the formation of a robust, stable compound Taylor cone for continuous coaxial electrospinning (Fig. 2B).Fig. 2Fabrication and characterization of in situ coaxial nanofibers. (A), Image of portable electrospinning device including the printing shell, battery case, and voltage board. B, Taylor cone in stable spinning state. (C) Scanning electron microscope images of PVA/PVP, PVB/PVP, AP@BP, and LECT2-AP@BP fibers. (D) Transmission electron microscope images LECT2-AP@BP. (E) Water contact angle. (F) Fourier-transform infrared spectroscopy. (G) Confocal microscopy images of the coaxial nanofibers with Calcein-labeled shell and Cy5-NHS-labeled LECT2. (H) Derivative thermogravimetric analysis of PVA/PVP, PVB/PVP, AP@BP, and LECT2-AP@BP fibers. (I) Cumulative release rate of LECT2. Fabrication and characterization of in situ coaxial nanofibers. (A), Image of portable electrospinning device including the printing shell, battery case, and voltage board. B, Taylor cone in stable spinning state. (C) Scanning electron microscope images of PVA/PVP, PVB/PVP, AP@BP, and LECT2-AP@BP fibers. (D) Transmission electron microscope images LECT2-AP@BP. (E) Water contact angle. (F) Fourier-transform infrared spectroscopy. (G) Confocal microscopy images of the coaxial nanofibers with Calcein-labeled shell and Cy5-NHS-labeled LECT2. (H) Derivative thermogravimetric analysis of PVA/PVP, PVB/PVP, AP@BP, and LECT2-AP@BP fibers. (I) Cumulative release rate of LECT2. This optimized formulation was fabricated using a custom-built, portable electrospinning device (Fig. 2A–S2A), engineered for tunable voltage and independent core/shell flow control via differentiated feeding chambers (Fig. S2C). The device operates at a safe output current of 1.23 mA (Fig. S3B) and is powered by an integrated system featuring a DC-to-AC converter and voltage regulator (Fig. S1C), fulfilling the requirements for safe and adjustable in situ deposition. Optimization and comprehensive characterization of core-shell fibers With the optimized polymer system established, we systematically investigated the processing parameters and corresponding material properties of the core-shell fibers. In coaxial electrospinning, the shell solution experiences the primary electric field force, and transfers momentum to the core via viscous drag. Consequently, the flow rate ratio between the shell and core solutions is a critical parameter governing successful fiber formation. We identified an optimal shell-to-core flow rate ratio of 3:1 to 4:1 for stable jet formation and core encapsulation (Fig. S4, Table S2). Deviations from this range resulted in structural failure: a 2:1 ratio produced fibers with two distinct diameters due to insufficient shell momentum for proper core encapsulation, whereas a 6:1 ratio yielded uniform but non-core-shell fibers, as confirmed by TEM (Fig. S4A and S4B). Under optimal conditions (3:1 ratio, 8 wt% PVP/PVA core, 10 wt% PVP/PVB shell), we fabricated the final LECT2-loaded (LECT2-AP@BP) and blank (AP@BP) fibers. SEM confirmed that all fiber groups formed continuous, cylindrical, and randomly interwoven networks (Fig. 2C). TEM directly visualized the well-defined core-shell bilayer structure of individual fibers (Fig. 2D). Minimizing the viscosity difference between the core (0.171 Pa s) and shell (0.167 Pa s) solutions was key to producing fibers with the smallest average diameter (284 ± 70 nm), a desirable feature for creating dense bacterial barrier networks (Table S3). Material stability in hydrated environment is paramount for wound dressings. Water contact angle measurements revealed that monolithic PVA/PVP fibers dissolved rapidly upon hydration. In contrast, the core-shell fibers maintained a stable hydrophobic interface (contact angle ∼105°) over 30 s without dissolution, confirming their integrity under moist conditions (Fig. 2E). Spectroscopic and thermal analyses provided further evidence of the composite structure. FTIR spectra of the core-shell fibers showed characteristic peaks of all constituent polymers, with a significant enhancement of the O-H stretching band, indicating strong intermolecular hydrogen bonding (Fig. 2F). Due to the low loading, LECT2's characteristic peaks were undetectable. Instead, confocal laser scanning microscopy of fibers with a fluorescently labeled shell (Calcein, green) and Cy5-tagged LECT2 (purple) clearly showed co-localized yet distinct fluorescent signals, confirming successful encapsulation of LECT2 within the fiber core (Fig. 2G). Thermogravimetric analysis (TGA) showed that the LECT2-AP@BP and AP@BP fibers exhibited nearly identical two-step degradation profiles, indicating a consistent composite material in which the trace protein load did not alter thermal stability (Fig. 2H). Finally, we evaluated the release kinetics of LECT2 via ELISA. The profile showed an initial burst release (∼25,000 pg within 12 h), likely due to rapid dissolution of surface-associated PVP and minor shell defects, followed by a sustained and slower release phase (∼2000 pg/24 h), reaching a cumulative total of 35,000 pg over 120 h (Fig. 2I). This biphasic release profile is advantageous for wound healing, providing an initial bioactive bolus followed by prolonged delivery. The release data of LECT2 were fitted to four common equations for drug release mechanisms (Table S4). The results indicated that the release profile was best described by the Ritger-Peppas equation (Fig. S5, R2 = 0.95013). The exponent n in the equation was 0.17949, which is less than 0.5, falling within the criteria of the Ritger-Peppas model and indicating Fickian diffusion. Collectively, this comprehensive characterization confirms the successful fabrication of structurally defined, stable, and functionally programmed core-shell fibers for controlled protein delivery. Functional performance of advanced wound dressings The functional efficacy of a wound dressing is determined by its mechanical integrity, moisture management, and fluid-handling capacity. We therefore conducted a systematic performance evaluation of our coaxial fibers against single-layer controls and commercial benchmarks. Superior Mechanical Integrity for Clinical Handling: Stress-strain analysis revealed distinct mechanical profiles depending on the material's composition (Fig. 3A–C). Monolithic PVA/PVP fibers exhibited high ductility (65% elongation at break) and tensile strength (2.5 MPa), consistent with the extensive hydrogen-bonding network of PVA. In contrast, PVP/PVB fibers showed poor mechanical properties (0.7 MPa strength, 8% elongation), likely due to weak intermolecular forces and potential phase separation. Critically, the AP@BP core-shell fibers displayed a unique and advantageous mechanical profile. Although their ultimate tensile strength (1.8 MPa) and elongation (25%) were intermediate, they possessed the highest elastic modulus (60-65 MPa), indicating superior resistance to elastic deformation, a property we attribute to the strong core-shell interfacial interaction. This combination ensures the dressing maintains structural integrity during application while retaining sufficient flexibility to conform to dynamic wound surfaces. The incorporation of LECT2 did not significantly alter these mechanical properties.Fig. 3Comprehensive performances evaluation of coaxial nanofibers. (A) Image of tensile test. B, stress-strain graphs. (C) tensile strength, elongation at break, and modulus of elasticity. (D) Water vapor transmittance of different dressings. E, swelling rate of PVP/PVB, AP@BP and LECT2-AP@BP fibers. Comprehensive performances evaluation of coaxial nanofibers. (A) Image of tensile test. B, stress-strain graphs. (C) tensile strength, elongation at break, and modulus of elasticity. (D) Water vapor transmittance of different dressings. E, swelling rate of PVP/PVB, AP@BP and LECT2-AP@BP fibers. Optimal Moisture Management for the Wound Microenvironment: Effective wound healing requires a balanced moisture environment. We measured the WVTR to assess breathability (Fig. 3D). The core-shell fibers (AP@BP and LECT2-AP@BP) exhibited a WVTR of approximately 3214 g/m2/day. This value lies strategically within the ideal range for dressings, positioned between the excessive dehydration risk of gauze (4525 g/m2/day) and the fluid accumulation risk of hydrogels (416 g/m2/day). Notably, it closely matches the elevated trans-epidermal water loss typical of wounded skin (∼5138 g/m2/day), thereby promoting an optimally hydrated microenvironment conducive to healing. Enhanced Exudate Absorption Capacity: The swelling ratio, critical for absorbing wound exudate, was significantly higher for the core-shell fibers (∼90%) than for single-component PVP/PVB fibers (∼53%) (Fig. 3E). We attribute this enhanced capacity to the composite architecture: while the PVB shell provides structural integrity, water penetrates through it to reach the highly hydrophilic PVA/PVP core, triggering substantial expansion. This dual mechanism allows efficient fluid uptake without structural disintegration. Comprehensive biocompatibility and hemocompatibility profile Prior to in vivo assessment, we rigorously evaluated the biosafety of our core-shell fiber system, including the LECT2 protein itself, through cytocompatibility and hemocompatibility assays. Confocal microscopy revealed that L929 fibroblasts adhered and spread effectively on both AP@BP and LECT2-AP@BP fibers, exhibiting well-defined actin cytoskeletons and focal adhesion plaques, indicating positive cell-material interactions and a favorable substrate for cellular growth (Fig. 4A).Fig. 4The biocompatibility of coaxial nanofibers. (A) Confocal microscopy images of L929 cells grown on LECT2-AP@BP nanofibers. Representative live/dead staining images (B) and cck-8 analysis (C) of L929 cells treated with coaxial nanofiber extracts for day 1, 2 and 3. (D) Hemolysis ratios of coaxial nanofibers. The biocompatibility of coaxial nanofibers. (A) Confocal microscopy images of L929 cells grown on LECT2-AP@BP nanofibers. Representative live/dead staining images (B) and cck-8 analysis (C) of L929 cells treated with coaxial nanofiber extracts for day 1, 2 and 3. (D) Hemolysis ratios of coaxial nanofibers. Living/dead staining demonstrated that LECT2 did not increase the cell dead level (Fig. 4B). Quantitative assessment using CCK-8 assays confirmed that extracts from both blank and LECT2-loaded fibers did not inhibit the metabolic activity or proliferation of L929 fibroblasts over 72 h, with viability levels remaining comparable to the control group (Fig. 4C). This non-cytotoxic effect was universal, as direct supplementation with LECT2 also did not alter the proliferation or viability of HaCat, Raw264.7, or HUVEC cells (Fig. S6A and S6B), confirming the inherent biocompatibility of the therapeutic protein. Hemocompatibility, a critical parameter for wound dressings, was assessed via hemolysis assay. The hemolysis rates for the AP@BP and LECT2-AP@BP fibers were measured at 0.17% and 0.32%, respectively (Fig. 4D), while the LECT2 protein alone exhibited a hemolysis rate below 3.2% (Fig. S4C). All values are significantly below the 5% safety threshold stipulated by the ISO 10993-4 standard, demonstrating that neither the composite fiber matrix nor its bioactive payload induces significant damage to red blood cells. In summary, these integrated findings provide a comprehensive safety profile. The core-shell fiber architecture supports robust cell adhesion and growth without eliciting cytotoxicity or hemolysis. Furthermore, the LECT2 protein itself is confirmed to be biocompatible and hemocompatible. This collective evidence firmly establishes the foundational biosafety of our LECT2-AP@BP platform, justifying its progression to therapeutic efficacy studies. LECT2-loaded core-shell fibers accelerate wound healing through enhanced angiogenesis, proliferation, and immunomodulation Having confirmed the biosafety and controlled release profile of our system, we next evaluated its therapeutic efficacy using a murine full-thickness excisional wound model. The LECT2-AP@BP fibers promoted a significantly accelerated wound closure rate compared to both the blank AP@BP fiber group and the control, as quantified by serial planimetry (Fig. 5A–C). Histological examination further confirmed a substantially reduced residual wound gap in the LECT2-AP@BP group (Fig. 5D), corroborating the macroscopic findings.Fig. 5The therapeutic evaluation of LECT2 incorporated CEF for in vivo wound healing. (A) Macroscopic observation of wound healing. (B) Schematic diagram of wound healing area and (C) quantification of wound healing (%). (n = 6). (D) H&E-stained skin wound tissue sections. The Immunohistochemistry staining and quantification of CD31 (E) and Ki67 (F), CD206 (G), and CD86 (H) in skin wound tissue sections (n = 3). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. The therapeutic evaluation of LECT2 incorporated CEF for in vivo wound healing. (A) Macroscopic observation of wound healing. (B) Schematic diagram of wound healing area and (C) quantification of wound healing (%). (n = 6). (D) H&E-stained skin wound tissue sections. The Immunohistochemistry staining and quantification of CD31 (E) and Ki67 (F), CD206 (G), and CD86 (H) in skin wound tissue sections (n = 3). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. To elucidate the cellular mechanisms underlying this enhanced repair, we analyzed key regenerative processes. Immunofluorescence staining revealed a marked increase in CD31+ vascular structures within the granulation tissue of the LECT2-AP@BP group (Fig. 5E). Given that CD31 is a well-established marker for vascular endothelial cells [22], this result indicates that the sustained release of LECT2 potently stimulates neovascularization, ensuring adequate nutrient and oxygen supply to the healing wound. Concurrently, we observed a significant upregulation of the proliferation marker Ki67 in the LECT2-AP@BP group (Fig. 5F). The elevated Ki67 signal, particularly within the wound epithelium and stromal cells, demonstrates that LECT2 creates a pro-regenerative microenvironment that fosters the robust cellular proliferation required for re-epithelialization and tissue regeneration [23]. Beyond direct tissue-building effects, wound healing is profoundly influenced by the inflammatory phase. A timely transition from pro-inflammatory (M1) to pro-healing (M2) macrophage polarization is critical for effective repair [3]. Our data indicate that LECT2 delivery actively orchestrates this immunomodulatory switch. We found a significant decrease in the M1 marker CD86 alongside a concurrent increase in the M2 marker CD206 in the LECT2-AP@BP group (Fig. 5G and H). This shift in the macrophage population from a pro-inflammatory toward an anti-inflammatory and pro-regenerative phenotype represents a key mechanism through which LECT2-AP@BP fibers mitigate excessive inflammation and promote a healing-conducive environment. In summary, the superior therapeutic performance of the LECT2-AP@BP fibers is mechanistically driven by a synergistic triad of effects: (1) enhanced angiogenesis to revascularize the wound bed, (2) stimulation of cellular proliferation to rebuild damaged tissue, and (3) intelligent immunomodulation of the wound microenvironment to resolve inflammation and promote regeneration. This multifaceted action underscores the potential of our protein-eluting core-shell fiber platform as an advanced therapeutic strategy for complex wound healing. In vivo biosafety and systemic biocompatibility of LECT2-Loaded nanofibers To complement our in vitro biosafety data, we conducted a comprehensive assessment of the systemic biocompatibility of the LECT2-loaded core-shell fibers in vivo. Following 10 days implantation period in a murine wound model, major organs (heart, liver, kidney) were harvested for histological analysis. H&E staining revealed no discernible pathological alterations, inflammatory infiltrates, or tissue damage in any of the examined organs from mice treated with either blank (AP@BP) or LECT2-loaded (LECT2-AP@BP) fibers, as compared to controls (Fig. S7A). To quantitatively assess potential subclinical toxicity, we performed a comprehensive serological panel. Critical markers indicative of hepatic function (AST, ALT, ALP, ALB, TBIL), renal function (CREA, UREA), and lipid metabolism (TC) all remained within normal physiological ranges and showed no statistically significant differences observed among all experimental groups (Fig. S7B). Unaltered levels of transaminases (AST, ALT) and bilirubin (TBIL) confirmed the absence of hepatotoxicity, while stable creatinine (CREA) and urea (UREA) levels verified unimpaired kidney function. Collectively, these findings provide critical in vivo evidence validating the excellent systemic biosafety of our drug-eluting nanofiber platform. The absence of histological abnormalities and the normal clinical chemistry profile indicate that the fibers, their degradation products, and the sustained release of LECT2 do not elicit acute or subacute systemic toxicity. Such favorable biocompatibility represents a pivotal prerequisite for the clinical translation of an implantable therapeutic system, thereby strongly supporting the safety and potential of our platform for clinical wound management applications. LECT2 promotes keratinocyte migration and confers antioxidant protection via the NRF2/SOD axis Building on the in vivo healing data, we sought to elucidate the underlying cellular mechanisms, focusing on re-epithelialization and oxidative stress management, two critical processes in wound repair. LECT2 Potently Stimulates Keratinocyte Migration: Efficient wound closure requires the rapid migration of keratinocytes to re-establish the epidermal barrier. We found that LECT2 treatment significantly enhanced the migratory capacity of HaCaT keratinocytes in a dose-dependent manner, as shown by both transwell and scratch assays (Fig. 6A, B, 6F, 6G). The pro-migratory effect was most potent at a low concentration (1 ng/mL), yielding a 2.8-fold increase in migration. Conversely, LECT2 knockdown markedly impaired cell migration (Fig. 6C–E, 6H, 6I). Furthermore, the extracts of LECT2-AP@BP fibers increased the keratinocytes migration than the LECT2 (Fig. S8). Mechanistically, LECT2 deficiency led to an upregulation of E-Cadherin and concomitant downregulation of N-Cadherin (Fig. 6J), indicating that LECT2 facilitates migration, at least in part, by promoting a cadherin switch, a hallmark of enhanced cellular motility and a key step in re-epithelialization. Future RNA-Seq analyses will be required to further elucidate the molecular mechanism underlying LECT2-mediated regulation of HaCaT migration.Fig. 6LECT2 promotes cell migration in HaCat cells. Transwell migration assay and quantification of HaCat treated with different concentrations of LECT2 (A, B) and LECT2-KD HaCat in 24 h (C, D, E) (n = 8). Scratch assay and quantification of wound healing area (%) of HaCat treated with different concentrations of LECT2 (F, G) and LECT2-KD HaCat in 12 h (H, I) (n = 8). J, The gene expression of E-Cadherin, N-Cadherin, and Vimentin (n = 3). Data are presented as mean ± SD. A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. KD, knockdown. LECT2 promotes cell migration in HaCat cells. Transwell migration assay and quantification of HaCat treated with different concentrations of LECT2 (A, B) and LECT2-KD HaCat in 24 h (C, D, E) (n = 8). Scratch assay and quantification of wound healing area (%) of HaCat treated with different concentrations of LECT2 (F, G) and LECT2-KD HaCat in 12 h (H, I) (n = 8). J, The gene expression of E-Cadherin, N-Cadherin, and Vimentin (n = 3). Data are presented as mean ± SD. A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. KD, knockdown. LECT2 Activates the NRF2/SOD Pathway to Ameliorate Oxidative Stress: The wound bed typically exhibits ROS that can impede the healing process. We investigated LECT2's ability to modulate the cellular antioxidant defense system. In both HaCaT keratinocytes and L929 fibroblasts, LECT2 administration (10 ng/mL) effectively reversed the H2O2-induced downregulation of key antioxidant enzymes including SOD1, SOD2, and SOD3 (Fig. 7A and B). This effect was accompanied by a significant upregulation of NRF2, a master regulator of the antioxidant response (Fig. 7A and B) [24]. Functionally, LECT2 treatment led to a substantial reduction in intracellular ROS levels in both cell types (Fig. 7C and D), confirming its efficacy in mitigating oxidative injury.Fig. 7LECT2 showed efficient anti-oxidative capability. (A, B) mRNA expression of antioxidant markers in HaCat and L929 cells treated with H2O2, and further LECT2 at different concentrations (n = 3). (C, D) ROS release in HaCat and L929 cells treated with H2O2, and further LECT2 at different concentrations (n = 12). (E) The regulatory mechanism summary of LECT2 against oxidative stimulation. Data are presented as mean ± SD (n = 6). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. LECT2 showed efficient anti-oxidative capability. (A, B) mRNA expression of antioxidant markers in HaCat and L929 cells treated with H2O2, and further LECT2 at different concentrations (n = 3). (C, D) ROS release in HaCat and L929 cells treated with H2O2, and further LECT2 at different concentrations (n = 12). (E) The regulatory mechanism summary of LECT2 against oxidative stimulation. Data are presented as mean ± SD (n = 6). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. The antioxidant role of LECT2 appears to be concentration-dependent. This finding provides a plausible resolution to a previously reported discrepancy, wherein a high concentration of LECT2 (∼480 ng/mL) was found to exacerbate ROS-mediated liver injury [5]. In contrast, our data demonstrate that at lower, physiologically relevant concentrations (1-10 ng/mL), LECT2 functions as a cytoprotective factor by activating the NRF2/SOD pathway to scavenge excessive ROS (Fig. 7E). This biphasic effect underscores the critical role of dose and context in determining LECT2's biological function. In summary, we have delineated a dual mechanism whereby LECT2 accelerates wound healing: it directly fuels re-epithelialization by activating keratinocyte migration, while concurrently safeguarding the wound microenvironment against oxidative damage by bolstering the endogenous NRF2/SOD antioxidant defense system. These findings position LECT2 as a multifaceted regulator of tissue repair. LECT2 orchestrates an anti-inflammatory microenvironment by driving macrophage M2 polarization Inflammation resolution constitutes a pivotal phase in wound healing, which is primarily driven by the phenotypic transition of macrophages from a pro-inflammatory M1 to a pro-regenerative M2 phenotype (Fig. 8A) [[25], [26], [27]]. We investigated whether LECT2 contributes to this immunomodulatory switch. In Raw264.7 macrophages, LECT2 treatment significantly suppressed the expression of classical M1 markers (Il-1β, IL-6, iNOS) while concurrently upregulating key M2 markers (Il-10, Tgf-β, Arg1, CD206) at the transcriptional level (Fig. 8B and C). Flow cytometry analysis at the protein level validated this phenotype shift, showing a marked reduction in the M1 surface marker CD86 and a concomitant elevation in the M2 marker CD206 (Fig. 8D and E). Furthermore, we utilized the extracts of AP@BP and LECT2-AP@BP to treat LPS-induced Raw264.7. Results showed that AP@BP extracts did not influence the expression of inflammatory related genes, while LECT2-AP@BP increased the M2 markers expression and inhibited the M1 markers expression (Fig. S9A and S9B). Collectively, these data unequivocally demonstrate that LECT2 drives functional macrophage polarization toward an anti-inflammatory, pro-healing M2 state.Fig. 8LECT2 showed efficient anti-inflammatory effects. (A) The regulatory process of macrophages from M1 to M2. mRNA expression of M1 (C) and M2 (D) macrophage-related markers. Flow cytometry analysis and quantification of CD86 (M1 macrophage marker) (E) and CD206 (M2 macrophage marker) (F) expression. Data are presented as mean ± SD (n = 3). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. LECT2 showed efficient anti-inflammatory effects. (A) The regulatory process of macrophages from M1 to M2. mRNA expression of M1 (C) and M2 (D) macrophage-related markers. Flow cytometry analysis and quantification of CD86 (M1 macrophage marker) (E) and CD206 (M2 macrophage marker) (F) expression. Data are presented as mean ± SD (n = 3). A significant difference between the groups, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. This finding, however, appears contradictory to previous studies reporting pro-inflammatory roles for LECT2 in other contexts, such as in adipocytes and during sepsis [4,28,29]. A critical analysis reveals that this functional duality is likely governed by concentration-dependent signaling. The previously reported pro-inflammatory effects were observed at supraphysiological concentrations (400-5000 ng/mL) [4,26,27]. In contrast, our study, along with another reporting a therapeutic effect in arthritis [30], utilized lower concentrations (<100 ng/mL). These findings establish a biphasic model for LECT2 immunomodulation: at low, physiological levels, it facilitates inflammation resolution and tissue repair, whereas at high, pathological concentrations, it can exacerbate inflammatory responses. Therefore, we identify LECT2 not as a universally pro- or anti-inflammatory cytokine, but as a context-dependent immunomodulator whose functional output is precisely tuned by its local concentration. The sustained, low-dose release from our core-shell fibers is ideally positioned to exploit this therapeutic window, actively resolving inflammation in the wound microenvironment by steering macrophages toward the regenerative M2 phenotype, thereby facilitating the progression to the proliferative phase of healing. Further studies utilizing RNA-Seq are warranted to elucidate the intracellular signaling cascades underlying LECT2-mediated regulation of macrophage polarization. LECT2 enhances angiogenesis under oxidative stress via receptor Tie1 in a biphasic manner To decipher the molecular mechanism underlying LECT2-mediated promotion of wound healing, we examined its direct effects on endothelial cells under the pathophysiological conditions of wound repair. Interrogation of a single-cell RNA sequencing dataset of human skin wound-healing revealed dynamic regulation of LECT2 receptors, characterized by a notable upregulation of the Tie1 receptor on days 7 and 30 post-wounding, a critical period for neovascularization (Fig. 9A and B). This finding suggests that Tie1 likely serves as the primary functional receptor mediating LECT2 signaling during the angiogenic phase of repair. Furthermore, LECT2 treatment promoted, while knockdown inhibited, the migration capacity of HUVEC cells (Fig. 9C–E).Fig. 9LECT2 promotes HUVEC cell migration. (A) The cell marker and subpopulation of skin during wound healing at 0, 1, 7, and 30 days. (B) the expression of LECT2 receptors in endothelial cells. Transwell migration assay and quantification of HUVECs treated with different concentrations of LECT2 (C) and LECT2-KD HUVECs in 24 h (D) (n = 8). Scratch assay and quantification of wound healing area (%) of HUVECs treated with different concentrations of LECT2 (E) (n = 8). Data are presented as mean ± SD. A significant difference between the groups, ∗∗p < 0.01, and ∗∗∗p < 0.001. KD, knockdown. LECT2 promotes HUVEC cell migration. (A) The cell marker and subpopulation of skin during wound healing at 0, 1, 7, and 30 days. (B) the expression of LECT2 receptors in endothelial cells. Transwell migration assay and quantification of HUVECs treated with different concentrations of LECT2 (C) and LECT2-KD HUVECs in 24 h (D) (n = 8). Scratch assay and quantification of wound healing area (%) of HUVECs treated with different concentrations of LECT2 (E) (n = 8). Data are presented as mean ± SD. A significant difference between the groups, ∗∗p < 0.01, and ∗∗∗p < 0.001. KD, knockdown. We next establish an in vitro model of the oxidative wound microenvironment by treating HUVECs with H2O2. Under these stress conditions, LECT2 exhibited a potent, biphasic effect on angiogenesis. At low concentrations (1 and 10 ng/mL), LECT2 administration significantly restored H2O2-impaired tube formation in HUVECs (Fig. 10A and B). This pro-angiogenic effect was corroborated by upregulation of key antioxidant enzymes (SODs) and pro-angiogenic genes (Fig. 10C and D). Conversely, LECT2 knockdown exacerbated oxidative damage, further impairing tube formation and downregulating gene expression of these genes (Fig. 10E–G).Fig. 10LECT2 increased angiogenic tube formation under oxidative conditions. (A) The angiogenic tube formation of HUVCEs treated with H2O2 and different concentrations of LECT2. (B) The statistics of branching length and node number. (C) The gene expression of antioxidant genes. (D) The gene expression of angiogenic-related genes. (E) The angiogenic tube formation of LECT2-KD HUVCEs. (F) The statistics of branching length and node number in LECT2-KD HUVCEs. (G) The gene expression of angiogenic-related genes in LECT2-KD HUVCEs. Data are presented as mean ± SD (n = 3). A significant difference between the groups: ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. KD, knockdown. LECT2 increased angiogenic tube formation under oxidative conditions. (A) The angiogenic tube formation of HUVCEs treated with H2O2 and different concentrations of LECT2. (B) The statistics of branching length and node number. (C) The gene expression of antioxidant genes. (D) The gene expression of angiogenic-related genes. (E) The angiogenic tube formation of LECT2-KD HUVCEs. (F) The statistics of branching length and node number in LECT2-KD HUVCEs. (G) The gene expression of angiogenic-related genes in LECT2-KD HUVCEs. Data are presented as mean ± SD (n = 3). A significant difference between the groups: ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. KD, knockdown. Strikingly, a higher LECT2 concentration (100 ng/mL) failed to confer this protective effect. This concentration-dependent activity provides a crucial resolution to a previously reported paradox, wherein LECT2 was shown to inhibit VEGF165-driven angiogenesis under normal culture conditions at 80 ng/mL [31]. Our data demonstrate that the functional outcome of LECT2 signaling is not only concentration-dependent but also critically determined by the cellular context, specifically, the presence of oxidative stress. In the pathological wound milieu, physiological levels of LECT2 promote endothelial resilience and angiogenic function, an effect that is saturated or reversed at supraphysiological concentrations. In summary, we uncover a novel, context-dependent role for LECT2 in wound angiogenesis. The signaling cascade is primed by the injury-induced upregulation of the Tie1 receptor on endothelial cells. Subsequently, LECT2, at concentrations relevant to the wound state, directly protects endothelial cells from oxidative stress and potentiates their angiogenic capacity, thereby providing a mechanistic basis for the enhanced neovascularization and accelerated healing observed in our in vivo model. Future studies employing RNA-Sequencing will be required to further delineate how the LECT2/Tie1 axis modulates inflammatory angiogenesis. LECT2 exhibits moderate, dose-dependent antibacterial activity Bacterial infection, particularly from S. aureus and MRSA, is a major complication that hinders wound healing [32]. We therefore investigated the direct antimicrobial activity of LECT2. Our results demonstrated that LECT2 treatment reduced the growth and biofilm formation of both S. aureus and MRSA in a dose-dependent manner (Fig. S10A and S10B). Live/dead staining further confirmed a higher proportion of dead bacteria in cultures treated with LECT2, providing direct visual evidence of its bactericidal effect (Fig. S10C). This antibacterial function aligns with previously reported innate immune roles for LECT2 in vertebrates [33]. Quantitatively, at a concentration of 100 ng/mL, LECT2 achieved moderate antibacterial rate of 41.3% against S. aureus and 31.8% against MRSA. Although this activity is falls below the high-efficacy threshold (typically >80%) required for materials designed primarily as antimicrobial agents, its significance within our therapeutic context remains substantial. Within our multifunctional wound-healing system, this moderate antibacterial activity serves as a valuable complementary feature. The primary healing mechanisms of LECT2 by enhancing angiogenesis, promoting cell migration, and resolving inflammation are now reinforced by its capacity to directly suppress bacterial proliferation and biofilm formation. This collective action creates a more holistic therapeutic profile, where LECT2 not only actively drives tissue repair but also mitigates one of the most prevalent obstacles to effective wound healing. Future studies to elucidate the precise molecular mechanism underlying its antibacterial action could guide the design of more potent LECT2-based analogs. Conclusions This study establishes a paradigm for active wound management by integrating advanced materials engineering and mechanistic biology. We designed and fabricated a portable, in-situ coaxial electrospinning device that produces a sophisticated core-shell nanofiber dressing for the controlled delivery of the hepatokine LECT2. This platform directly addresses key clinical challenges: it forms a stable, breathable barrier upon application and maintains a sustained, localized release of the therapeutic protein. Our comprehensive investigation reveals that LECT2 acts as a master regulator of wound repair, driving healing through a synergistic trilogy of mechanisms: it fuels tissue regeneration by directly stimulating keratinocyte migration and angiogenesis; it resolves oxidative stress by upregulating the NRF2/SOD antioxidant defense pathway; and it modulates the immune response by facilitating the critical transition from pro-inflammatory M1 to pro-healing M2 macrophages. The in vivo efficacy of this system is underscored by significantly accelerated wound closure, driven by enhanced CD31+ neovascularization, Ki67+ cell proliferation, and a reshaped immune landscape. Ultimately, this work makes a dual contribution: firstly, it introduces a versatile and portable platform for the in-situ deposition of advanced, drug-eluting biomaterials. Secondly, it provides profound mechanistic insight into LECT2 as a potent, multi-functional therapeutic agent for regenerative medicine. This LECT2-loaded coaxial nanofiber system represents a significant leap forward from passive wound coverings to intelligent, all-in-one healing platforms with high clinical translation potential. Ethics approval and consent to participate All animal procedures were approved by the Institutional Animal Care and Use Committee of Guangdong Huawei Testing Co., LTD, Guangzhou, China (approved number: 202202002) and performed in accordance with relevant guidelines. Fundings This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (U22A20159), 10.13039/501100021171Guangdong Basic and Applied Basic Research Foundation (2023A1515030055) and 10.13039/501100013058Key Technologies R&D Program of Dongguan (20221200300072). CRediT authorship contribution statement Zhichao Zheng: Formal analysis, Investigation, Writing – original draft. Jiasheng Mao: Formal analysis, Investigation, Writing – original draft. Haohui Zhu: Formal analysis, Investigation, Writing – original draft. Zhihe Fu: Investigation. Wei Xie: Investigation. Shaofen Xu: Investigation. Yan Wang: Investigation. Shuiqing Yu: Investigation. Ziyi Liu: Investigation. Lijing Wang: Conceptualization. Richard T. Jaspers: Conceptualization, Project administration. Janak L. Pathak: Conceptualization, Project administration, Supervision, Writing – review & editing. Huade Zheng: Conceptualization, Project administration, Supervision, Writing – review & editing. Lihong Wu: Conceptualization, Investigation, Project administration, Writing – review & editing. Declaration of competing interest The authors declare no competing interests.